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Transboundary zoonotic diseases, several of which are vector borne, can maintain a dynamic
focus and have pathogens circulating in geographic regions encircling multiple geopoliti-
cal boundaries. Global change is intensifying transboundary problems, including the spatial
variation of the risk and incidence of zoonotic diseases.The complexity of these challenges
can be greater in areas where rivers delineate international boundaries and encompass tran-
sitions between ecozones.The Rio Grande serves as a natural border between the US State
ofTexas and the Mexican States of Chihuahua, Coahuila, Nuevo León, andTamaulipas. Not
only do millions of people live in this transboundary region, but also a substantial amount of
goods and people pass through it everyday. Moreover, it occurs over a region that functions
as a corridor for animal migrations, and thus links the Neotropic and Nearctic biogeographic
zones, with the latter being a known foci of zoonotic diseases. However, the pathogenic
landscape of important zoonotic diseases in the southTexas–Mexico transboundary region
remains to be fully understood. An international perspective on the interplay between dis-
ease systems, ecosystem processes, land use, and human behaviors is applied here to
analyze landscape and spatial features of Venezuelan equine encephalitis, Hantavirus dis-
ease, Lyme Borreliosis, Leptospirosis, Bartonellosis, Chagas disease, human Babesiosis,
and Leishmaniasis. Surveillance systems following the One Health approach with a regional
perspective will help identifying opportunities to mitigate the health burden of those dis-
eases on human and animal populations. It is proposed that the Mexico–US border along
the Rio Grande region be viewed as a continuum landscape where zoonotic pathogens
circulate regardless of national borders.
Keywords: Lyme borreliosis,VEE, Hantavirus, Babesia, Chagas, Leishmania, pathogenic landscapes, global change
INTRODUCTION
The United States (US) and Mexico share a border spanning
3,100 km from the Gulf of Mexico to the Pacific Ocean. Approx-
imately 14 million people reside within the area found roughly
100 km on either side of the international line between the two
countries, with 7.3 million residing in the US and 6.8 million in
Mexico (1). A bi-national effort is in place to protect the envi-
ronment and public health in the US–Mexico border region that
is consistent with sustainable development. The sector encom-
passing the border States of Texas, Tamaulipas, Nuevo León, and
Coahuila includes at least 29 municipalities on the Mexican side
and 168 cities and towns on the US side, covers portions of the
Southern Texas Plains and Western Gulf Coastal Plain ecoregions
of Texas, and lies within a zoonotic disease hotspot (1–3). It
appears that conditions leading to the emergence of zoonotic dis-
eases as a public health threat in the US and other parts of the
world may be at play in the transboundary region covering south
Texas and Northeast Mexico (4–7). Among these factors, we have
poverty. For instance, in southern US, 16.5% of the population is in
poverty, and 22% of children under 18 years old live in such condi-
tions in the same region [National Center for children in poverty1
(8)]. Texas has a poverty level (17.6%) higher than the national
average (15%) calculated as a 3-year average. In addition, recent
1http://www.nccp.org
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studies showed that migrants displaced due to adverse weather
conditions related to climate change, are predicted to increase dur-
ing the twenty-first century (9, 10). Economically, deficient areas
will be highly impacted with these types of extreme weather events,
making this population more vulnerable to emerging infectious
diseases due to an increase in out-migration flow (9).
These scenarios acquire special relevance in the US–Mexico
border, one the largest and longest-sustained routes of human
migration. From the human migratory standpoint, the States of
Chiapas and Tabasco in Mexico play a vital role as transit points for
large numbers of people. In this regard, the ports of entry are the
Ocosingo and Tapachula surroundings in Chiapas, and Tenosique
in Tabasco. Veracruz is therefore the transition point for the nearly
400,000 individuals, representing approximately 50 nationalities,
who traverse Mexico each year with the ultimate goal of reach-
ing the US (Migration Department, Mexican Interior Ministry
2006). All these individuals are forced to cross areas that might
be “hot spots” of Babesiosis, Venezuelan equine encephalitis virus
(VEEV), and other pathogens that have incubation periods fluctu-
ating between 3 and 10 days (3). Consequently, the “One Health”
approach is required to enhance the ability to recognize zoonotic
pathogens in humans, domestic, and wildlife reservoirs and the
associated vectors in the US and Mexico transboundary region.
This concept states simply that clinicians, researchers, agencies,
and governments must work together seamlessly for the benefit of
animal and human health as well as for the welfare of the global
environment.
An international perspective on the interplay between disease
systems, ecosystem processes, land use, and human behaviors is
applied in this review paper to analyze landscape and spatial fea-
tures of Venezuelan equine encephalitis (VEE), Hantavirus disease,
Lyme disease (LD), Leptospirosis, Bartonellosis, Chagas disease,
Babesiosis, and Leishmaniasis all of which can be considered, or
have the potential to be emerging zoonotic infectious diseases of
relevance in this transboundary region (Table 1) (11–15).
PATHOGENIC LANDSCAPE
GLOBAL CHANGE AND EMERGENCE OF VECTOR-BORNE ZOONOTIC
DISEASES
As the world globalizes in terms of Nation’s economies and
increased travel, borders are opened for a constant flow of goods,
products, and pathogen dissemination. Likewise, as human pop-
ulations expand into new geographical regions, the possibility
that humans will come into close contact with infectious agents’
potential hosts, which can transmit pathogens to human beings,
increases. Such factors, combined with increased human density
and mobility, stand as a serious human health threat. Addi-
tionally, climate change is increasingly becoming a concern in
the emergence of zoonotic infectious diseases (16). For the past
70 years, most of the newly emergent diseases have been identi-
fied as zoonoses (60.3% of EIDs), and the majority (71.8%) has
originated in wildlife (17). Thus, according to the transbound-
ary zoonotic disease concept, understanding how these pathogens
emerge in different geographical regions will directly benefit global
trade and public health. Here, we review several diseases that
could impact a geographically strategic region in the US and Mex-
ico border area. Insights gained understanding the pathogenic
landscape of these zoonotic diseases could help enhance predic-
tive tools, which might be applied to study the epidemiology of
other transboundary pathogens. Pathogenic landscape is a term
used to describe attributes of an ecosystem that influence spatial
variations in disease risk or incidence (18).
Emission of greenhouse effect gasses has impacted global
climate (19), increasing Earth’s surface temperature 0.74°C on
average (20). According to the 2002 World Health Organization
(WHO) report, climate change has caused approximately five
million disability-adjusted life years (DALYs) in the world (21).
Moreover, the 2007 Intergovernmental Panel on Climate Change
report (22) and the 2014 National Climate Assessment by the US
Global Research Program (16), suggest that climate change will
affect North America at multiple levels, such as public health, agri-
culture, water supply, and frequency of extreme weather events,
among others (15). Increased temperatures, sea levels, precipita-
tions, and droughts due to climate change can drastically change
the epidemiology of vector-borne diseases (15, 21, 23, 24), as both
vectors and pathogens are very sensitive to these climatic variables.
Climate change can potentially alter the spatial range of vector-
borne diseases through shifts in geographical distributions of their
vectors (14, 25, 26). Despite some positive developments, such as
better access to clean drinking water, lower exposure to insect
vectors, and higher-quality housing, projected changes in climate
over the next decades may exacerbate infectious disease incidence
even in developed regions such as North America (15). Habitat
changes, alterations in water storage and irrigation habits, pollu-
tion, development of insecticide and drug resistance, globalization,
tourism, and travel are additional factors that may aggravate this
threat (26). For instance, in Europe, short winters appear to have
influenced populations of Dermacentor reticulatus, the tick vec-
tor responsible for transmission of Babesia canis, to expand to
the East (20). In Veracruz, Mexico, a study found an association
between an increase in dengue cases and increased temperature
and rainfall that followed El Niño Southern Oscillation (ENSO)
events (27). Increased rainfall could create both microclimates, in
which vectors can thrive, as well as cause high temperatures, which
could allow for a rapid increase in vector densities and ultimately
put humans at risk for vector-borne disease. Extreme-flooding
events can cause outbursts of zoonotic diseases caused by infec-
tious agents transmitted by rodents, as their pathogen-containing
urine contaminates the water. This was the case in Nicaragua, in
which a Leptospirosis epidemic followed a flooding event (28).
Thus, humans might face increasing exposure to zoonotic dis-
eases as naturally occurring phenomena like ENSO and flooding
events are expected to become frequent due to climate change
(23). In addition, climate change can also affect the epidemiology
of zoonoses indirectly. For instance, the density of vegetation in a
particular area increases during heavy rainfall seasons. This vege-
tation indirectly supports the reproduction of rodents, which can
be infected with pathogens transmissible to humans (29).
Human migration and economic trade can exacerbate cli-
mate change influences on vector-borne diseases along the Texas–
Mexico border. Ecological niche models, under climate change
scenarios, showed an increased distribution of Leishmaniasis vec-
tors and reservoirs in Texas and North Mexico (14). A recent
study in the Texas–Mexico border identified the present and future
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Table 1 |Transboundary zoonotic diseases, distribution, agents, vectors, and transboundary relevance in the US–México border region.
Disease Distributiona Etiologic agent Vector Transboundary relevance
VIRUS
VEE Meso-America,
Southern Texas, and
Northern Mexico
Venezuelan equine
encephalitis virus
Culex (Melanoconion) taeniopus Shared vectors and reservoirs
Deinocerites pseudes Human migration
Aedes (Ochlerotatus) taeniorhynchus Livestock movement
Mammalophilic mosquitoes
HPS and HFRS American continent,
Europe, Asia, Africa
likely worldwide
Hantavirus Wild rodents of the Cricetidae and
Soricidae families serve as reservoirs
Shared reservoir species across border
Human migration
Different public health preparedness
Poverty (suboptimal housing)
BACTERIA
Lyme disease US, Mexico, Canada Borrelia burgdorferi Ticks Shared vectors and reservoirs
Ixodes scapularis Different public health policies
I. pacificus
Leptospirosis Worldwide Leptospira
interrogans
Wild rodents serve as reservoirs Shared reservoir species across borders
Human migration
Livestock movement
Different public health policies
Poverty (suboptimal housing, sanitation,
and hygiene)
Rocky mountain
spotted
fever/Brazil
spotted fever
US, Mexico, Canada,
Costa Rica, Panama,
Colombia, Uruguay,
Argentina, Brasil
Rickettsia rickettssi Ticks Shared vectors and reservoirs
Dermacentor variabilis
D. andersoni
Rhipicephalus sanguineus
Amblyomma cajennense
Haemaphysalis leporispalustris
Human
monocytic
ehrlichiosis
US, Mexico Ehrlichia chaffensis Ticks Shared vectors and reservoirs
E. ewingiie A. americanum
D. variabilis
I. pacificus
Human
granulocytic
anaplasmosis
US Anaplasma
phagocytophilum
Ticks Shared vectors and reservoirs
I. scapularis
I. pacificus
Bartonellosisb Americas, Europe,
Asia
Bartonella henselae Ticks Shared vectors and reservoirs
Ba. quintana I. pacificus Human migration
Ba. bacilliformi I. scapularis Livestock movement
Ba. vinsonii subsp.
berkhoffii
I. ricinus Poverty (poor sanitation, hygiene and
crowded housing environments)I. persulcatus
D. reticulatus
D. marginatus
R. sanguineus
R. microplus
Sand flies
Lutzomyia verrucarum
L. columbiana
L. peruensis
Licec
Pediculus humanus humanus
P. capitis
Fleasc
Pulex irritans
(Continued)
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Table 1 | Continued
Disease Distributiona Etiologic agent Vector Transboundary relevance
PROTOZOA
Human
Babesiosis
US Babesia microti Ticks Shared vectors and reservoirs
I. scapularis
I. pacificus
I. texanus
D. variabilis
Chagasd American Continent Trypanosoma cruzi Triatoma sanguisuga Shared vectors and reservoirs
T. gerstaeckeri Human migration
T. lenticularia Different public health policies
Poverty (suboptimal housing)
Leishmaniasis Americas Leishmania
(Leishmania)
Lutzomyia sand flies Shared vectors and reservoirs
Human migration
Different public health policiesLeishmania (Viannia)
aAdapted from Ref. (173).
bWith relevance to this review paper.
cHuman body and head lice, and human fleas. Other species have been associated with wildlife and domestic animals (173).
dAs per Ref. (298, 304).
eIn the US only.
potential distribution, under climate change scenarios, of the LD
vector, Ixodes scapularis (13). The results of this study indicated
that South Texas includes suitable habitat for I. scapularis. In a
similar study, the potential future distribution of main Chagas
disease vectors, Triatoma gerstaekeri and T. sanguisuga, is expected
to increase in the Texas–Mexico border due to climate change (12).
Temperature and precipitation played a major role in the models
presented in these three studies.
The transboundary region between Mexico and the US is
vulnerable to outbreaks of vector-borne diseases because some
Southern States, such as Texas, share a legacy of neglected trop-
ical diseases (NTD) (30) with Mexico. This situation highlights
the urgency to develop and deploy active surveillance programs,
which are necessary for optimal management and control of
vector-borne diseases.
EFFECT OF EXOTIC WEEDS ON VECTOR POPULATIONS
Invasive weeds can change the ecology of, and induce a patho-
genic landscape in which arthropod-borne disease transmission
can increase. Mack and Smith (31) link invasive plants as cat-
alysts for the spread of human parasites by documenting the
escape and mast seed production of Asian frost-tolerant bamboos
from cultivation in the Pacific Northwest to potential outbreaks
of the omnivorous deer mouse Peromyscus maniculatus that car-
ries Hantavirus. Invasive weeds also interact with ticks. Japanese
barberry has been shown to increase the abundance of the black-
legged tick, I. scapularis and the infection prevalence of Borrelia
burgdorferi (LD) (32, 33). In India, Kyasanur forest disease of cattle
and monkeys is attributed to disturbance of the native forest for
tea plantations, which resulted in invasions of the invasive weed
Lantana camara and outbreaks of Haemaphysalis spiniger, the vec-
tor for Kyasanur encephalitis-inducing virus within the flavivirus
group (34). The clearing of the native forest in Argentina and the
transition to exotic African grasses increased the impact of cat-
tle fever ticks (CFT) by increasing the encounter rate with cattle
(35). This same pathogenic landscape phenomenon appears to be
happening in the permanent quarantine zone (PQZ) in the Texas–
Mexico border region, with the invasion of the exotic and invasive
weed species, Arundo donax known as the giant reed (Figure 1).
Aerial remote sensing pictures of the Rio Grande taken in 2002
indicate that 62% or 5981 ha of riparian habitat on Rio Grande
from Big Bend to Falcon Dam was infested with giant reed, which
includes most of the PQZ (36). Zoonotic agents are not transmit-
ted by CFT, but knowledge from the study of CFT ecology can be
applied to understand how ecosystem shifts can influence spatial
variation in disease risk or incidence for tick-borne disease systems
of public health importance.
Giant reed impacts the USDA-APHIS Cattle Fever Tick Erad-
ication Program (CFTEP) along the transboundary region of
Texas–Mexico border. Giant reed indirectly affects CFT because
survival is highest in giant reed as compared to native riparian
vegetation or buffel grass pastures (37). Abiotic conditions within
giant reed stands are cooler due to the heavy shade and high rates
of evapotranspiration (ET), which appears to be cause of lower
levels of CFT mortality. Biotic conditions in giant reed stands are
also altered because the abundance of CFT arthropod predator
species is reduced (37). In a review of the literature records of pre-
dation on ticks, Samish & Alekseev (38) documented that ground
dwelling predators (e.g., ants, beetles, and spiders) are the major
natural enemies of ticks. Preliminary pitfall trap surveys in the
PQZ indicate that ground dwelling beetle populations, specifically
the predaceous Carabidae and omnivorous Tenebrionidae species,
are strongly reduced in giant reed compared to adjacent native
plant communities (Goolsby, personal communication). Ants are
also known to be important predators of ticks in Texas. Fleetwood
et al. (39) documented reduced populations of Lone Star ticks,
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FIGURE 1 | Invasion of exoticArundo donax, giant reed, is facilitating
the invasion of Cattle FeverTicks in the transboundary region by
creating a microclimate that is favorable for its survival. (A) Arundo
donax on Rio Grande near Eagle Pass, TX, USA. (B) Arundo donax on Rio
Grande near Del Rio, TX, USA.
Amblyomma americanum, in pastures with abundant red imported
fire ants, Solenopsis invicta. Fire ant predation is generally believed
to reduce the incidence of tick-vectored pathogens of livestock. In
Louisiana, fire ant predation of Ixodes ticks was associated with
a reduced incidence of Anaplasmosis in cattle (40). Preliminary
studies in the PQZ found that ant diversity and abundance is low in
giant reed stands, with the red imported fire ant, Solenopsis invicta,
being the most common species. Comparative studies are needed
to survey ant diversity throughout the PQZ to investigate their
potential impact on CFT. Control of exotic giant reed and restora-
tion of the native riparian vegetation could reduce the favorability
of this habitat for CFT and lead to restoration of a more intact leaf
litter insect predator community and in total a more robust biolog-
ical barrier to invading CFT and other tick-borne zoonoses. Giant
reed may also be creating a localized climatic refuge for CFT when
conditions in the upland habitat are not favorable for survival. As
giant reed declines, lower ET rates, increased ground temperatures,
and lower humidity levels are expected in these riparian habitats
and these conditions are known to reduce the survival of larval and
adult CFT (41–45). Giant reed also indirectly impacts the CFTEP
by reducing visibility in the PQZ along the Rio Grande. Heavy
infestations of giant reed make it extremely difficult for mounted
inspectors to detect and capture stray livestock.
Exotic weeds interact with disease vectors in the transboundary
region between Texas and Mexico. These weeds create a landscape
that is depauperate of beneficial predators of disease vectors and
alter the microclimate, and as such, they can facilitate the invasion
of these vectors and must be considered in their full ecological
context.
ZOONOTIC INFECTIOUS DISEASES
VIRAL INFECTIOUS DISEASES
Venezuelan equine encephalitis
Venezuelan equine encephalitis viruses are members of the VEE
complex and comprise the three major serogroups of New World
alphaviruses (46, 47). Fourteen subtypes and varieties have been
described within the VEEV complex (48). The IAB and IC viruses
are designated “epidemic” or “epizootic” because they have been
isolated only during equine and human outbreaks. They are dis-
tinct from enzootic strains (subtypes/varieties ID-F, II-VI) that
circulate in sylvatic or swamp habitats, and occasionally cause
disease in humans or domestic animals (48–50). Importantly,
VEEV isolates identified to be of the IE subtype identified dur-
ing epizootics in Mexico appear to be equine neurovirulent, but
are unknown to produce high titer viremia (50). Transmission
cycles have been described for most of the enzootic VEE sub-
types/varieties [ID, IE, II, IIIA, and IIIB (Tonate)], except III
C and V (48). Most of them are transmitted among rodents
by mosquitoes in the subgenus Culex (Melanoconion) and few
mammalophilic mosquitoes (51).
Venezuelan equine encephalitis virus was known to be circu-
lating and producing illness in horses since the 1920s (49, 51),
and in 1938 the virus was isolated from the brain of a horse
that died of encephalitis in South America (52–54). Human cases
with neurological complications were recorded in 1950 during
an outbreak of febrile illness in Espinal, Colombia (55). VEEV
outbreaks continued at regular intervals through the 1960s in
South America affecting tens-to hundreds-of-thousands of peo-
ple (50, 56). Between 1973 and 1992 no VEEV was documented,
which led to the assumption that the epidemic-epizootic subtypes
IAB and IC VEEV had disappeared (50). However, phylogenetic
studies and renewed epidemic/epizootic VEE activity in North-
western Venezuela during 1992–1993 revealed that these viruses
remain a threat (57, 58). Two equine epizootics in the States of
Chiapas and Oaxaca, Mexico caused by a subtype IE virus (59),
and a major outbreak in Venezuela and Colombia during 1995
affecting about 100,000 people (60, 61) draw attention to the con-
tinued threat of VEEV. To date,VEEV viruses affecting humans and
equids have been found in at least 12 countries of the Americas
causing important social and economic damage mainly in Latin
America (48).
Most VEEV epizootics and epidemics have taken place in
Northern South America and in regions of Venezuela and Colom-
bia. However, VEE has also affected North America on several
occasions. In 1966, an equine epizootic in Northeastern Mexico
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was reported in southern Tamaulipas and Northern Veracruz
within the Panuco river basin (62). Although no viruses were iso-
lated, VEE etiology was determined serologically. The lack of VEE
vaccination in Mexico at this time suggests that this outbreak was
caused by a local enzootic subtype IE strain. Another major Middle
American outbreak and one of the most devastating VEEV pan-
demics of the Continent, began near the Guatemala-El Salvador
border on the Pacific coast and spread through much of Central
America, Mexico, and Texas during 1969–1972, and involved tens-
of-thousands of equines and people. In Mexico, equine deaths
from VEE were first reported in 1969 in mountainous regions
of the State of Chiapas close to the Guatemalan border (63). By
1970, the epizootic had produced about 10,000 equine deaths
in the States of Chiapas and Oaxaca (64). The outbreak then
spread northward to the Gulf Coast and eventually reached South-
ern Texas. In Texas, approximately 1500 horses died of VEE, and
several hundred human infections were documented. The Texas
outbreak was halted by a massive equine vaccination program
and aerial insecticide spraying costing about 15 million dollars
(50, 65).
In the 1990s, two outbreaks of equine encephalitis occurred on
the Pacific Coast of Southern Mexico. From June to July in 1993,
125 equine cases including 63 deaths were reported in Chiapas
State. Three years later, from June to July in 1996, another equine
epizootic occurred nearby in Oaxaca State, involving 32 horses
with 12 deaths (59, 66). Epidemiological and serological data were
consistent with VEE, and VEEV was isolated from encephalitic
horses involved in each outbreak. No human cases were docu-
mented during these outbreaks. However, further serosurveys and
VEEV isolations obtained in the same area of the 1990s outbreaks
demonstrated that VEE has been endemic in this Southern region
of Mexico for decades (67).
Two virus isolates from the Mexican outbreaks of the 90s were
examined antigenically and genetically. All were VEE subtype IE
by IFA and ELISA using monoclonal antibodies (68). Sequenc-
ing and phylogenetic studies indicated that the outbreak strains
belong to one of three major subtype IE VEEV lineages. This lin-
eage circulates on the Pacific Coast of Guatemala, and was sampled
there from 1968 to 1980 (59, 66). The absence of previous Mexi-
can isolates from this lineage suggests that the currently circulating
Mexican strains originated from enzootic transmission foci on the
Pacific Mexican Coast. The remaining IE lineages circulate on the
Gulf and Caribbean Coasts of Central America (Nicaragua north-
ward to the Gulf Coast of Mexico and close to the US border)
and in Western Panama, and differ by up to 7% at the nucleotide
sequence level.
Before the Chiapas–Oaxaca outbreaks, isolates of enzootic
VEEV, including subtype IE, were traditionally believed to be
avirulent for equines, and were not previously known to have epi-
zootic potential (69–71). Experimental infection of horses with
several IE strains from Mexico and Nicaragua showed that these
viruses generally produced little viremia and disease (70, 71). Fur-
ther studies using reverse genetics approaches demonstrated that
Aedes (Ochlerotatus) taeniorhynchus, an abundant epizootic vec-
tor in coastal areas of Chiapas and Oaxaca, was more susceptible
to isolates obtained during the 1993 and 1996 epizootics com-
pared with closely related enzootic IE strains isolated previously
in Guatemala (72). A mechanism of VEEV emergence was sug-
gested showing that a single Ser→Asn amino acid substitution
at position 218 of the E2 envelope glycoprotein was the major
determinant of the increased Ae. taeniorhynchus infectivity. Viral
adaptation to a vector that prefers to bite large mammals was sug-
gested as the emergence mechanism in the 1990s outbreaks of
Southern Mexico (72).
Subtype IE enzootic viruses are the only VEEV known to con-
tinuously circulate in Mexico both currently as well as prior to 1993
outbreak. They occur from Western Panama through Tamaulipas
State in Mexico (48, 65, 73–75). The ecology of the IE viruses has
been studied in detail and Culex (Melanoconion) taeniopus is the
known primary enzootic vector of subtype IE viruses in Guatemala
(76), and one of the principal vectors maintaining endemic VEEV
cycles in southern Mexico, the Gulf Coast of Mexico (48, 73, 75),
and Panama (65). It has been demonstrated that Cx. taeniopus
found in estuarine areas of Chiapas is susceptible to both subtype
IE VEEV isolates from the Pacific Mexican outbreaks of the 90s
and to strains isolated from hamster sentinels during the 2000s
in the same region (77). Cx. taeniopus feeds on a wide variety
of hosts, mainly small rodents from the Cricetidae family such
as cotton rats and rice rats, and seems to circulate subtype IE
VEEV not only in the Mexican Pacific Coast but also in the Gulf
Coast of Mexico (73, 77). The scenario in the Pacific Coast of
Southern Mexico appears to involve VEEV transmission by Ae.
taeniorhynchus to equids and possibly humans at inland locations
(48). The threat of VEEV outbreaks in the Mexican Pacific region
involving enzootic and epizootic vectors exists (48). Such region is
linked to the East through Gulf river basins where several endemic
VEEV foci are found, along the States of Tabasco, Veracruz, and
Tamaulipas. The later of these States is adjacent to the US Texas
border, and is a spot of subtype IE VEEV activity (73). Hotspot
activity was characterized through serosurveys suggesting VEEV
infections in cattle, equines, rodents, and humans, which was com-
plemented with the isolation of IE VEEV (73). Findings of the
study showed that at least one major urban region (Minatitlan in
the State of Veracruz) has active enzootic VEEV transmission with
Cx. taeniopus identified as the main VEEV vector (74; Estrada-
Franco and Weaver, unpublished information). Several mosquito
epizootic vectors of VEEV that were found infected and active
during the VEEV pandemic of the 1970s are present on both
sides of the border (Tamaulipas and Texas), such as Ae. sollici-
tans, Psorophora confinnis, and Ae. taeniorhynchus (63, 78). The
risk of Ae. taeniorhynchus or other epizootic vectors adapting to
endemic VEEV cycles elsewhere outside the Chiapas area, as was
demonstrated with the IEVEEV strains isolated in the Pacific coast,
could be of veterinary and public health significance. An epidemic
strain of VEEV has the potential to arise from circulating endemic
strains, which may be easily misdiagnosed for another febrile-
causing disease if appropriate diagnostic assays are not routinely
performed. The movement of epidemics by viremic individuals is
a major concern, particularly in the Gulf Coast region of Mexico,
which could threaten previously unaffected areas of Mexico and
even the US. Moreover, direct human-to-human transmission of
VEEV has also been suggested by the sudden appearance, rapid
increase, and brief occurrence of human disease within affected
communities (61, 79).
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Reconstructing the historical incidence of VEE could facilitate
the forecast of recurring patterns and help improve strategies for
disease prevention, e.g., vaccine distribution logistics. Our hypoth-
esis is that drivers of VEE outbreaks are responsive to heavy rainfall
events but activity subsides as drier conditions return.
The historical time-series shows three repeating VEE outbreaks
over the past century, recurring at approximately 30-year intervals,
and spanning up to one decade. The gap of two decades follow-
ing each outbreak period is conspicuous (Figure 2). Attention to
details of each major outbreak show striking differences between
epidemics. The first event (Outbreak I, 1935–1946) is exclusively
an equine outbreak, with a locus in Columbia and Venezuela. By
1942, it had spread to Peru in the South and by 1943 to Trinidad
in the East. The actual number of equines affected in this out-
break was not documented, and there are no records of human
VEE cases; the latter do not appear as recorded observations until
the 1960-decade. The gaps over the 1970–1980 decades (Gap b)
and over the 1996–2013 interval (Gap c) contrast, at least in terms
of recent serological evidence, and in terms of important climatic
conditions.
The ocean indicators both show low levels of storm impact over
the 1972–1992 (Gap b), and likely reflect the paucity of extreme
rainfall events, which is in contrast with the high storm levels over
the 1996–2013 interval (Gap c) (Figure 2). The latter suggests hur-
ricane and ENSO events are now opportune to bring heavy rainfall
into the VEE-affected region. This begs the question of why recent
VEE levels remain relatively low and points to the need for fur-
ther analysis of local rainfall and other weather events across the
region.
There is uncertainty and considerable concern over the possi-
ble re-emergence of an outbreak of VEE. Our time-series model
and its correlation with broad climate signals (Figure 2) offers
a new and evocative look at VEE at the century and cross-
regional scales. It opens a window on a conceptual framework
for better understanding and managing outbreaks of the virus
through both the tracking of accelerated climate change (e.g.,
satellite imagery), and use of long-term forecasting (Figure 3).
Work is in progress using power spectrum analysis to quantify
likely timing and magnitude of future outbreaks. This is impor-
tant now that serological analyses show the widespread presence
of the VEE virus in humans, equines, and populations of virus
reservoirs like the rodent species mentioned above, which mos-
quito vectors feed on, that respond to unusually strong rainfall
events.
The development and persistence of high Accumulated
Cyclonic Energy Index (ACE) and equatorial Pacific Ocean South-
ern Oscillation Index (SOI) levels imply VEE outbreak activity
currently and in the near future (Figure 2). Why VEE outbreak
activity has remained low since 1966, when broad oceanic indi-
cators suggest a high potential for outbreak, remains unknown,
which indicates the need for further research. For example, addi-
tional research into local rainfall conditions could help understand
how mosquito populations expand, which may drive VEEV activ-
ity as it has been shown in other mosquito-borne arboviral disease
systems (80). Conditions since the 1972–1992 gap have changed,
moving toward better virus monitoring and disease management
approaches. These changes, taken with the movement of human
populations into cities and a relative decline in equine popula-
tions, will also play a role in decreasing the likelihood or severity
of a VEE outbreak. There is currently widespread mosquito con-
trol in response to dengue epidemics. Any of these developments
may be limiting the magnitude of current and near-term VEE epi-
demics (Figure 3). Outbreaks in the 1930s and 1960s were weakly
constrained, at best, and may offer a study in contrast to mod-
ern conditions with better knowledge and disease management
infrastructure.
Hantavirus
The genus Hantavirus, from the family Bunyaviridae, is composed
of viruses with a three-segment negative sense RNA genome (81,
FIGURE 2 | IntegratedVEE area-severity index. Integrated VEE
area-severity index (dark solid line, left axis) based on historical
reconstruction of areal extent and severity in equine and human
populations over the 1920 through 2013 period. Three major VEE outbreaks
(I, II, III) and three gap-intervals (a, b, c) of low VEE are shown.
(A) Eleven-year running means of accumulated cyclonic energy index
(ACE, red font ) and (B) the Southern Oscillation Index (SOI, green font )
given on right axis.
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FIGURE 3 | Observed integrated area-severity index forVenezuelan
equine encephalitis (VEE) in the Americas, 1920–2010. Integrated
Area-Severity (IAS) index (dark solid line, left axis, log10 scale, 5-year
point-centered moving average) for Venezuelan Equine Encephalitis (VEE) in
the Americas, based on reconstruction of actual disease incidence reported in
literature, 1920–2010. Hypothetical reconstruction of expected levels of VEE,
1920–2010, achieved by sequential repeat of the average IAS index levels over
Outbreak Two (1950–1979) and Outbreak Three (1980–2009) (dashed line,
right axis, log10 scale), with standard error of mean added (light vertical lines).
Outbreak One (1920–1949) values excluded from average due to lack of solid
data. Subdued levels of VEE over Outbreak Three could be the result of
assertive mosquito control programs related to dengue fever epidemics,
and/or improved VEE management approaches and infrastructure (see text for
details).
82). In nature, these viruses are hosted by a variety of rodent
and soricomorph species as persistent infections (81). Humans
acquire Hantavirus infection by inhaling aerosolized particles
from rodent excreta and urine, or via the bite of an infected ani-
mal (81). Some rodent-borne Hantaviruses are associated with
two types of human disease, differing between the New and Old
Worlds. In the Americas, Hantavirus pulmonary syndrome (HPS)
has reached fatality rates of 60% and is characterized by ele-
vated pyrexia, pulmonary dysfunction, and cardiac shock (83).
In several regions of the Old World (Europe, Russia, China and
Korea), hantaviral infections cause a hemorrhagic fever with renal
syndrome (HFRS) characterized by high fever, renal dysfunc-
tion, and hemorrhage but with mortality rates usually lower than
12% (81, 83).
A relevant feature of Hantaviruses is their close association
between a specific Hantavirus and its rodent host species, suggest-
ing a strong relationship between Hantaviruses and their reservoirs
(84, 85). Globally, these viruses occur in close association with
rodent and shrews of the families Cricetidae and Soricidae, with a
majority of New World Hantaviruses detected in reservoir rodent
species of the sub-family Neotominae (82, 86). Throughout Amer-
ica, more than 30 Hantaviruses have been identified, but only a few
have been associated to HPS (81). The New World geographic
distribution of known hantaviral strains includes Canada, US,
Mexico, Honduras, Costa Rica, Panama, Venezuela, Peru, Bolivia,
Brazil, Argentina, Chile, and Paraguay (81, 83). Rodents with Han-
tavirus antibodies have been detected in Peru, Venezuela, Costa
Rica, Honduras, and Mexico, although HPS in humans has not
been documented in these countries (81, 87). The distribution
of recorded cases of HPS and the distribution of Hantavirus
seroprevalent rodents in the Americas is not coincidental for sev-
eral reasons: (1) not all Hantaviruses have been associated with
HPS; (2) our knowledge of hantaviral diversity present in the con-
tinent is likely incomplete; and (3) HPS may be confused with
clinically similar diseases. In North America, five Hantaviruses
known to cause HPS are the Sin Nombre virus (SNV), New York
virus (NYV), Choclo virus (CHOV), Black Creek Canal virus
(BCCV), and Bayou virus (BAYV) (83, 88). SNV is the major cause
of HPS in the US and Canada, where Peromyscus maniculatus (deer
mouse) is the primary rodent reservoir (81, 89).
Northeastern Mexico (Chihuahua, Coahuila, Nuevo León, and
Tamaulipas) and Texas share a common biogeographic history,
and thus a large number (23) of Cricetinae rodent species are
shared among these States (90, 91). Because the abiotic environ-
ment and rodent assemblages of Northeastern Mexico are similar
to those of areas in the adjacent US, it is likely that many viruses
circulating in this region occur on both sides of the international
border. However, specific information regarding the prevalence
and spatial distribution of Hantaviruses within this region is
scarce and incomplete. Hantavirus antibody-positive rodents from
seven species have been found in Chihuahua, Nuevo León, and
Tamaulipas. The only Hantavirus identified to date within these
species is the SNV. However, because most of the rodent indi-
viduals tested were only analyzed by serology tests, it is possible
that other Hantaviruses occur in Northeastern Mexico (88, 92,
93). In Texas, antibodies for Hantaviruses have been detected in
11 rodent species and 4 Hantaviruses (SNV; El Moro Canyon
virus, ELMCV; Muleshoe virus, MULV; and BAYV) are known
to occur in this state (94). No cases of HPS are known from Mex-
ico, but up to 2006 a total of 28 confirmed cases were recorded in
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Texas. Of these, 24 cases were associated to SNV and 3 to BAYV.
Infection with SNV had a high mortality rate of 50% (12/24),
but all of the three patients infected with BAYV survived (95).
The geographic distribution of HPS cases in Texas shows the two
groups with most cases (64%) are in the West and Panhandle
areas, with the rest of the cases found along the Gulf of Mex-
ico Coast area. This disjoint case distribution is due to rodent
reservoir distributions. Cases along the Gulf Coast are associated
to the BAYV, which is carried by the rice rat (Oryzomys palus-
tris), whereas the cases in Western Texas have been related to SNV
presence in the deer mouse (P. maniculatus) (95). O. palustris is
present in Northeastern Mexico, but no seropositive individuals
have been reported. Its role as a BAYV reservoir in Mexico is likely
minor as the range of this rodent is limited to the extreme North-
ern corner of Tamaulipas (90). However, two rodent species (P.
maniculatus, and the white-footed mouse, Peromyscus leucopus)
pose a more serious risk for HPS along the transboundary States.
Both species have wide ranges across Texas and Northeastern Mex-
ico; within this region, SNV seroprevalent individuals have been
recorded for both species (88, 94, 95). Moreover, based on the
list of Hantaviruses identified in the Southwestern US, it is sug-
gested that four Hantaviruses likely circulate in Northern Mexico:
SNV, ELMCV, MULV, and Limestone Canyon virus (LSCV). These
viral strains are hosted by rodent species of the Peromyscus, Rei-
throdontomys, and Sigmodon genera (88), which are ubiquitous
throughout the transboundary region. This hypothesis needs to
be confirmed with further work to ascertain the public health risk
for human populations on both sides of the border. To achieve
this goal, it is necessary to determine the geographic distribution
patterns of Hantavirus sero-prevalence in rodent reservoir species
and understand the mechanistic processes that determine these
patterns.
Beyond knowing the specific situation in the Eastern trans-
boundary region between Mexico and the US, further work needs
to extend outside of this zone, as it might influence this region.
Mexico has a very diverse mammalian fauna (~525 species) with
rodents comprising almost half (235 spp., 44.8%) of the species
(90). It is possible that many more species harbor Hantaviruses
than those currently recognized (88). Specifically, the transbound-
ary region could serve as a connection between Hantaviruses
of Neartic origin with others from tropical regions. The State
of Tamaulipas has a mammalian fauna that represents a mix
of Neartic and Neotropical taxa (90) and the possibility exists
that these rodent species of Neotropical affinities could harbor
Hantaviruses found in tropical areas such as the Catacama virus
(CATV) present in O. couesi from Honduras (83, 87). Moreover,
evidence of the presence of Hantavirus seropositive rodents in
regions of Southern Mexico and crucial human migration crossing
pathways are elements to be considered in this complex equation
(88). For instance, in the State of Chiapas’ coastal and central val-
leys, there are clear indications for the presence of Hantavirus in
wild life. After infection, the resultant disease can take up to 2 weeks
to develop in the human host, allowing the disease to move with
relatively low detection. Thus, the potential risk of these Neotrop-
ical Hantaviruses existing in the transboundary region needs to be
evaluated.
BACTERIAL INFECTIOUS DISEASES
Tick-borne bacterial infections
Globally, ticks serve as vectors for a number of zoonotic bac-
terial pathogens, such as the spirochete Borrelia burgdorferi, the
causative agent of LD, as well as the intracellular pathogens Rick-
ettsia rickettsii, Ehrlichia chaffeensis, E. ewiingii, and Anaplasma
phagocytophilum (Table 1), also known as tick-borne rickettsial
diseases (TBRD) (96). These pathogens are maintained in natural
cycles involving wild mammals and several species of hard ticks in
the family Ixodidae. Foci of LD exist in the US, Europe, and Asia,
and it is considered an emerging infection in those parts of the
world (97–101). In the US LD is the most prevalent arthropod-
borne infection with over 30,000 cases reported to the Centers
for Disease Control and Prevention (CDC) in recent years. The
increase in LD cases during the last few years has prompted its
classification as an emerging infectious disease. Similar to other
arthropod-borne diseases, LD is a complex system subject to
shifts in ecological processes that influence vector biology and
the epidemiology of B. burgdorferi infection in reservoir hosts and
humans.
Hard tick species in the genus Ixodes are recognized generally
as common vectors of B. burgdorferi. I. scapularis and I. pacifi-
cus are known competent vectors in the US, while I. persulcatus
and I. ricinus are the documented vectors in Eurasia (99, 102–
105). The pathogen is maintained in the environment by different
vertebrate hosts with varying degrees of competence. The main
reservoir, the white-footed mouse, Peromyscus leucopus, is found
in the forests of Eastern North America (106, 107). There is an
extensive bibliography on the molecular diversity and adaptation
of B. burgdorferi to its natural environment, as well as on the
impact of species diversity in a particular area on reducing LD risk
(108–118). In addition, some of these studies have also considered
the effect of climate change on the geographic distribution of I.
scapularis in addition to its phenology in the US and Canada (119–
121). Although LD in humans is more prevalent in Northeastern
US, the lack of detailed studies in Southern US has prevented
comparisons, and evaluations of ecological factors responsible for
promoting the differential incidence of LD between these regions.
Moreover, in some parts of the world the ecology and epidemiol-
ogy of LD remain to be fully understood. Thus, LD is considered
a transboundary zoonotic disease in that it can reach epidemic
proportions in regions of the globe regardless of country borders
(122). This is coupled with the fact that there is unequally dis-
tributed knowledge about the ecology of this disease among the
regions in which it occurs.
Human risk of infection with B. burgdorferi across the con-
tinental US has been predicted using the density of I. scapularis
infected nymphs (DIN) (123, 124). Under this scenario, Southern
US States were considered as a low risk region given the non-
appearance of host-seeking I. scapularis nymphs at sampled sites
(123, 124). In striking contrast to the conclusion of this suggested
null risk of acquiring LD in Southern States, a steady number of
LD cases have been reported in these low risk areas every year (125,
126). Some of the caveats of these most recent studies include the
lack of accounting for both human movement (some cases can
be acquired in a region different from the one where they are
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reported) and differences in tick phenology between geographic
areas (124). These limitations might explain why the models uti-
lized cannot explain the variation in distribution of the disease
observed in low incidence areas. Drivers for the variation in dis-
tribution of disease cases observed in low incidence areas remain
to be identified.
In Mexico, a national serosurvey of human serum samples
reported a B. burgdorferi sero-prevalence of 1.1% (127). The
Mexican States of Tamaulipas, Nuevo León and Coahuila in the
Texas–Mexico border region presented the highest sero-prevalence
(6.4%) for the country (128). Also, Ixodes ticks infected with
B. burgdorferi sensu stricto occur in the same States (129), and
recently the infection has been documented in white-tailed deer
(130). Distribution models of potential tick vectors in Mexico
point to a wide distribution range that overlaps not only North-
eastern Mexican States along the border with the US, but also
extend to central Mexico (131, 132). These studies, together with
confirmed clinical cases of LD acquired in parks near Mexico
City (133, 134), demonstrate the existence of a zoonotic cycle
responsible for LD in Mexico.
TBRD are a group of zoonoses clinically similar, yet epidemi-
ologically and etiologically distinct. In the US, these diseases
include: (1) Rocky Mountain spotted fever (RMSF), (2) human
monocytic ehrlichiosis (HME), (3) human granulocytic anaplas-
mosis (HGA) (135), (4) Ehrlichia ewingii infection, and (5) other
emerging TBRD (Table 1). TBRD are common occurrences in
the medical and veterinary clinical setting, and are gaining more
attention from physicians and veterinarians since TBRD continue
to cause severe illness and death in otherwise healthy individ-
uals (136, 137). The epidemiology of these diseases reflects the
geographic distribution and seasonal activities of vectors and
reservoirs and human behavior that places persons at risk for
infection through tick bite (13, 129, 137, 138). Environmental
changes may alter the distribution of wild animals and arthropod
vectors, which could extend their range to areas close to human
populations where these pathogens could be transmitted (13).
But demographic and sociologic factors also play a critical role
in determining disease incidence.
Several ticks species are vectors of different rickettsiae causing
TBRD. R. rickettsii, the causative agent of RMSF, is transmitted
most frequently by the American dog tick (Dermacentor vari-
abilis) in the Eastern, Central, and Pacific coastal US and the
Rocky Mountains, while the wood tick (D. andersoni) transmits
this pathogen in the Western US. The brown dog tick (Rhipi-
cephalus sanguineus), a vector of RMSF in Mexico (129, 137, 139),
was implicated in 2005 as vector of this disease in a confined geo-
graphic area in Arizona (140). Rhipicephalus ticks from Mexicali,
Mexico have been recently genetically characterized, and found to
be different from those isolated in the US (141). The cayenne tick
(Amblyomma cajennense) is a common vector for RMSF in Cen-
tral and South America (129, 132, 142), and its range extends into
the US through Texas. Ehrlichia chaffeensis and Ehrlichia ewingii
are transmitted to humans by the lone star tick (Amblyomma
americanum). E. ewingii infections in dogs or ticks have been
described in Missouri, Oklahoma, Tennessee, Arkansas, Texas,
Florida, Georgia, Mississippi, North Carolina, and Virginia (143,
144). A. phagocytophilum is transmitted by the blacklegged tick
(I. scapularis) and is distributed in New England, North Central,
and recently, Southeast United States, in addition to the Northeast
of Mexico (13, 129). The western blacklegged tick (I. pacificus)
is the principal vector in Northern California. In the US, the esti-
mated average annual incidence of RMSF was 2.2 cases per million
people. In Mexico, the incidence from 1975 to 1987 was 12.59 cases
per 100,000 people in North and Northwest States. From 2009 to
2011, there were 2616 reported cases with an incidence of 0.8 cases
per 100,000 people. In 2012, there was an increase to 2875 cases
in the States of Baja California and Coahuila in Northern Mexico.
Due to the consistent increase and presence of this disease, Mex-
ico started to officially report RMSF and other Rickettsial human
cases in 2014 (145).
Ehrlichiosis was first recognized as a disease in the late 1980s,
but did not become a reportable disease until 1999 in the US. The
number of ehrlichiosis cases due to E. chaffeensis that have been
reported to CDC has increased steadily since the disease became
reportable, from 200 cases in 2000 to 961 cases in 2008 (138).
The incidence increased from less than 1 to 2.5 cases per million
people in 2000–2010. Both E. chaffeensis and E. ewingii are causes
of human illness in the US, although the majority of reported
cases identify E. chaffeensis as the causative agent of HME. HGA
is more frequently reported than HME with an annual incidence
of 1.6 cases per million during 2001–2002. In Mexico, the first
Ehrlichiosis case was reported in 1999 (146). It is important to
understand the involvement of dogs in the potential enzootic cycle
for Ehrlichia infection acquired by humans in close contact with
domestic dogs. In this sense, our research team found that human
contact with Ehrlichia infected dogs have 14.9 times higher risk
to become infected, and dogs infested with Ehrlichia infected ticks
have 8.2 higher risk of being infected (128).
The understanding of vector-borne disease ecology has
improved in recent years due to advancements in molecular biol-
ogy, geographic information systems (GIS), and species distri-
bution models (SDM) (147, 148). A recent study evaluated the
presence of I. scapularis ticks in Texas and Northern Mexico, and
forecasted the distribution of this tick species considering different
climate change scenarios (13). It was observed that a geographic
region could provide suitable environment where the competent
vector for transmission of LD and other zoonotic pathogens would
survive. The model presented in this study showed East Texas to
include suitable habitat where established populations can exist
(13), which agrees with findings from other studies (149). This
model also showed expansion towards Central and to South Texas
through a corridor along the Gulf Coast and Northern Mex-
ico, forming a geographic continuum of habitat suitable for I.
scapularis populations in the border region. Although no specific
distribution model exists for I. scapularis in Mexico, a distribution
model for the genus Ixodes generated with similar methodologies
predicts a wide distribution covering Northeastern Mexico (132).
Variation in questing behaviors may significantly impact the
type of hosts ticks encounter and may lead to differential host
use within a particular study area (150). Therefore, further studies
testing different sampling procedures, including different time of
the day and season, would be needed to determine the phenol-
ogy of I. scapularis in Southern US and Mexico and the questing
behavior of the different developmental stages. These studies will
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be critical to determine how questing behavior will affect the risk
for LD in humans and companion animals in the transboundary
region.
Leptospirosis
Leptospirosis is a zoonotic infectious disease of worldwide distri-
bution that is endemic in tropical and temperate climates, with
higher prevalence in tropical countries (151–153). Leptospiro-
sis can be caused by Leptospira interrogans, which in cludes 200
serovars affecting both domestic and wild mammals, and humans
(153, 154). The reservoirs for these pathogens are wild or domes-
tic animals such as rodents, cattle, or dogs (155). In urban areas,
rodents (mostly rats) are the main carriers of the disease (156),
whereas the dog is considered a dead-end host (157,158). However,
due to their close contact, dogs pose a risk of infection for human
beings (151, 159). It has been suggested that ticks are potential
vectors of Leptospira spp. (160).
In the forest region of Indiana, a study was conducted with 34
raccoons (Procyon lotor) to determine the presence of Leptospira.
In this study,cell culture techniques,microscopic agglutination test
(MAT),and PCR were used. The results indicated the presence of L.
interrogans, L. kirschneri, and L. borgpetersen in raccoons from this
region. For L. interrogans, the serovars most frequently detected
were Bratislava (38.2%) and Grippotyphosa (32.4%). This finding
indicated that L. interrogans is circulating in the raccoon popula-
tion, which is acting as a reservoir for the pathogen. The racoon is
an abundant species in the south Texas – northeast Mexico region.
Cervids may be involved in the epidemiology of leptospiro-
sis. Diversified livestock production comprises activities aimed
to breed in sustainable manner wild animals, including native
and exotic species of deer. Ranches in northeast Mexico have
been managed to be units for the conservation, management,
and sustainable use of wildlife (UMA), which are dedicated to
the diversification of livestock. A cross-sectional epidemiological
study on leptospirosis was conducted with cervids at an UMA
in Tamaulipas, Mexico (161). Of the 37 animals sampled, eigh-
teen individuals were Axis deer (Cervus axis) and 19 Fallow deer
(Cervus dama). Seropositivity for Leptospira spp. in all the cervids
sampled was 13.5%. Twenty-one percent of the Axis, and 5.5%
of the Fallow deer were seropositive. Positive deer were reactive
to serovars Bratislava and Muenchen, which confirms the pres-
ence of this pathogen in deer in Northern Mexico (161). Similar
seroepidemiological findings for leptospirosis in cervids have been
reported in the US and Spain (162–165).
It is important to understand how global change may alter the
pathogenic landscape of leptospirosis because this zoonosis is con-
sidered a major bacterial NTD in Texas and Mexico (11). For exam-
ple, the water buffalo (Bubalus bubalis) is originally from Asia and
was introduced in Mexico as an alternative livestock species during
the 1990s (166). Water buffaloes produce milk, meat, and are used
as working animals. Although subclinical Leptospira infection has
been documented in other parts of the world and is considered a
health risk to humans, information is lacking on the prevalence
of leptospirosis in water buffalo herd in Mexico. An epidemio-
logical cross-sectional study was conducted with a sample size of
368 blood specimens in the Mexican state of Veracruz to fill this
knowledge gap. The overall sero-prevalence for Leptospirosis was
53.5% (167). The most common serovars detected were Muenchen
(44.3%), Pyrogenes (11.4%), Icterohaemorragiae (11.1%), and
Hardjo (8.1%). In this study, the interaction between water buf-
faloes and dogs was identified to be a risk factor (167). This was
the first study identifying seropositive buffaloes to L. interrogans
and risk factors associated with Leptospirosis in Mexico (167).
Zoonoses common to pets threaten the health of humans,
particularly children. A study conducted to determine the fre-
quency of canine Leptospirosis in dogs from two shelters in the
city of Veracruz, Mexico showed that 8.6% (8/92) were seroposi-
tive. The most frequent serovar was Canicola (168). Similar results
were observed in Yucatan, Mexico where the serovars present
were Canicola and Icterohaemorrhagiae (169). Even though lep-
tospirosis occurs in the transboundary region, more research is
required to understand its epidemiology and mitigate the bur-
den of this neglected zoonosis on human and domestic animal
populations (11).
Bartonellosis
Bartonella species are fastidious gram-negative, facultative intra-
cellular bacteria that cause host restricted hemotropic infections
in mammals. Normally, they infect erythrocytes, macrophages,
and endothelial cells. In addition, a number of Bartonella spp. are
transmitted by blood sucking arthropods such as sand flies, biting
flies, lice, and fleas. More recently, ticks and mites have been sug-
gested as potential vectors for zoonotic Bartonella spp. (170–175).
In addition, Bartonella spp. affect a number of mammals, includ-
ing humans, dogs, horses, cattle, cats, and even marine animals
(176, 177).
The number of Bartonella spp. identified infecting a wide range
of mammalian species has significantly increased. Currently, a
total of 13 species or subspecies can cause disease in humans, and
most of them are zoonotic (173, 176, 178). Bartonella henselae, the
causative agent of cat-scratch disease (CSD) is the most recognized
in the medical community together with B. quintana, the causative
agent of Trench Fever, and B. bacilliformes, the causative agent
of bacillary angiomatosis, Oroya fever and veruga peruana (176,
177). Moreover, most of the Bartonella species causing disease
in humans and companion animals have a worldwide distribu-
tion, and are associated with poverty and overpopulation, as these
bacteria thrive in crowded and unhygienic environments (172,
179–181). This aspect of B. quintana and B. elizabethae infections
has been extensively reviewed elsewhere (180–184).
Cats have been classified as reservoirs for B. henselae, the
causative agent of CSD, which is distributed worldwide. The preva-
lence of infection in felines is higher in warmer countries that it
is in cold countries (178). In addition, cats tend to be bacteremic
for months and in some instances for over a year (178). The cat
flea (185), Ctenocephalides felis, is responsible for the transmis-
sion of the bacterial pathogen between cats. Studies by Finkelstein
and collaborators (180) showed that B. henselae can remain viable
in flea feces for over 72 h. Therefore, transmission to humans can
occur via inoculation of B. henselae from infected flea feces into the
skin via open wounds, such a scratch lesion. The CDC documents
over 20,000 CSD cases annually. Human cases have been reported
in Texas (186–189), Mexico, and other Latin American countries
(190, 191). Domestic dogs, together with wild canids, have been
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suggested as potential reservoirs for zoonotic Bartonella species,
such as B. vinsonii subsp. berkhoffii, B. henselae, B. clarridgeiae,
B. wahoensis, B. rochalimae, B. quintana, and B. elizabethae. In
some cases, domestic dogs display a broad range of clinical signs
(174, 176, 178, 192, 193) similar to those observed in humans.
Consequently, domestic dogs might be considered sentinels for
Bartonella infections (178) as they are for other vector-borne
infectious diseases (194–196).
The number of annual cases due to Bartonella infection in the
US–Mexico transboundary region remains unknown even though
more epidemiological information is available relative to bacte-
rial NTD like leptospirosis (197). Bartonella infections are not
reportable in humans or animals in the US and Mexico. This
situation makes it difficult to understand the epidemiology and
pathogenic landscape for Bartonellosis in a geographic region
where about 17.6% of the population lives in poverty2.
PROTOZOAN INFECTIOUS DISEASES
Human babesiosis
Human Babesiosis (HB) is caused by several species of apicom-
plexan tick-borne protozoa of the genus Babesia and is a zoonotic
emerging disease globally although it is endemic in the US (198–
200). Surveillance for Babesiosis started in 2011 in 18 States.
That year, there were 1,124 confirmed and probable human cases
across the US (126). Most cases of naturally transmitted HB in the
Northeastern and Midwestern US are caused by B. microti (201).
Infection in other regions of the US and the world has been docu-
mented with Babesia species that remain to be fully characterized
(202–204). In rural Mexico, human infection with Babesia spp.
was documented during the 70s (205), where 37% of the tested
individuals were seropositive but asymptomatic, and all volunteers
recalled having tick bites.
HB is a complex zoonotic disease system whose relevance as an
emerging public health concern is considered to be the result of
aspects related to global change (206, 207). Most zoonotic Babesia
species are maintained in wildlife reservoirs, but gaps exist in our
knowledge of several epidemiological aspects of HB in various
parts of the world (208–210). The vector(s) and reservoir hosts of
Babesia species affecting humans in Mexico and other Latin Amer-
ican countries remain unknown (211). Accurate diagnosis of HB
in sub-tropical and tropical parts of Latin America can be com-
plicated because of malaria-like symptoms in the case of affected
patients (212), asymptomatic infection in others, and the possi-
bility that tick bite may have resulted in co-infection with other
tick-borne pathogens (213, 214) coupled with the use of serodiag-
nostic tools that cross-react with other Babesia and Plasmodium
hemoparasites (215, 216). Thus, it is important to understand
how environmental change (217), including the knowledge of vec-
tors and reservoir hosts, could influence the patterns of zoonotic
Babesia transmission at the regional level to evaluate the risk
for the emergence of Babesiosis among humans in the South
Texas–Northeast Mexico transboundary region.
Although its known geographic range appears to be expanding,
it is possible that HB remains under-reported in the South Texas –
Northeast Mexico transboundary region (218–220). Increasing
2http://www.census.gov/hhes/www/poverty/data/incpovhlth/2012/tables.html
evidence suggests that reservoir species and vectors are present in
the Eastern sector of the border between the US and Mexico, and
our knowledge of wildlife and domestic animals harboring Babesia
species with the potential to be pathogenic to humans is expanding
(204, 221, 222). The infection of cotton rats (Sigmodon hispidus)
and raccoons (Procyon lotor) with B. microti presents a risk for
HB in Northeast Florida (223). Both mammals are abundant in
Texas and Northeast Mexico (129, 142, 224, 225). I. scapularis is the
known vector in the Northeastern US and its presence has been
documented in the US–Mexico transboundary region (13), but
Clark et al. (223) suggested that additional Ixodes species might be
transmitting B. microti in the Southeastern US, like the raccoon
tick (I. texanus) and other Ixodes ticks known to feed on the cotton
rat. I. texanus is distributed in Texas and Nuevo León (142, 226,
227). Of the ticks species present in the US and Mexico, which
are known to infest the cotton rat (13, 228–230), D. variabilis and
I. scapularis have been shown to harbor Babesia spp. and bite
humans in Southern latitudes (231, 232). Suspected vectors of a
Babesia detected in the woodrat (Neotoma micropus) with a partial
18S rRNA sequence related to B. conradae included A. inornatum
and D. variabilis, which are ticks reported to parasitize humans
in Texas (233, 234). A. inornatum is found in the Mexican border
States of Coahuila, Nuevo León, and Tamaulipas (142, 235). Blood
donors from Texas were seropositive for B. duncani, but the vector
and reservoir host species remain to be determined (236). Notably,
four adult A. americanum and one adult D. variabilis PCR positive
for Babesia spp. were removed from humans in Texas (231). One of
the A. americanum was infected with a large Babesia molecularly
resembling a large Babesia detected in an immunocompromised
dog residing in Texas (237). Nevertheless, the zoonotic poten-
tial of the other Babesia infecting A. americanum remains to be
determined.
Global change is altering the distribution of ticks and tick-
borne diseases globally, and the South Texas–Northeast Mexico
transboundary region is not immune to this process (13, 198,
238). Environmental drivers for the emergence of HB as a public
health concern in other parts of the world seem to be at play in
the Texas–Mexico border (219, 231, 232). Assessing the incidence
of HB accurately requires knowledge of the rates for human-tick
contact and infection in the vector population. However, HB is
considered to be under-reported, even in states with a surveillance
program and areas where the disease is known to be endemic
(201). Diagnosis can be complicated because of co-infection with
B. burgdorferi and Plasmodium spp. (239, 240). It remains to be
determined if co-infection with B. burgdorferi and Babesia spp.
affecting humans occurs in populations of I. scapularis inhab-
iting ecosystems spanning the US–Mexico border. However, the
presence of potential vectors and reservoirs indicates that studies
are required to determine if zoonotic Babesiosis is an unrec-
ognized cause of illness among humans in that transboundary
region. Tick-based surveillance has been proposed as an alterna-
tive approach to assess infection risk because it provides a more
sensitive method for identifying areas where Babesiosis could be
emerging, and could be used to estimate zoonotic prevalence in
established areas (218). The adaptation of this strategy, with an
international perspective and in the context of the One Health
concept is suggested, as it was done recently for LD, to establish an
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early warning system for the emergence of HB in the Texas–Mexico
border region (13, 241).
Leishmaniasis
Leishmaniasis is a vector-borne disease caused by Leishmania
species of the family Kinetoplastidae, which is transmitted by sand
flies of the genus Lutzomyia in the Americas and Phlebotomus in
other regions of endemicity (242, 243). There are 98 countries
where Leishmania is endemic, with the majority of cases occur-
ring in developing nations (244). The distribution of competent
vector species and leishmaniasis has expanded over the last decade
as areas with suitable habitat for sand flies continue to increase
due in part to shifts in climate (14). Of the 1.6 million new cases
per year estimated to occur worldwide, approximately 600,000
are recorded (245). Moreover, leishmaniasis is estimated to affect
about 12 million people in four continents (Africa, Americas, Asia,
and Europe) (245, 246).
The leishmaniases have been divided in two main syndromes:
Old World, and New World leishmaniasis (247). Old World leish-
maniasis includes two clinical presentations: cutaneous leishma-
niasis, which is confined to skin, and visceral leishmaniasis, which
involves the bloodstream and inner organs. New World leishmani-
asis’ clinical presentation can manifest in a cutaneous form, or as
a mucocutaneous syndrome, which involves mucous membranes
in addition to the skin (245, 246). Presently, new terms are used
to describe the clinical forms of leishmaniasis. The term mucosal
leishmaniasis indicates the involvement of mucosal tissues such
as mucous membranes of the upper respiratory tract and oral
cavity, i.e. mucocutaneous leishmaniasis (246). Together with the
cutaneous and diffuse cutaneous forms the mucocutaneous syn-
drome is one of the typical presentations of leishmaniasis in South
America (248).
Twenty-one Leishmania species have been identified as human
pathogens. They are systematically classified in four complexes.
In the New World leishmaniasis is caused by species belonging to
the subgenus Leishmania [such as Leishmania (Leishmania) mexi-
cana, L. (Leishmania) amazonensis] and the subgenus Viannia [L.
(Viannia) braziliensis, L. (Viannia) panamensis, and L. (Viannia)
guyanensis] (246, 249). In Mexico and US, cutaneous leishmani-
asis is caused by a number of Leishmania spp. with widespread
distributions and a variety of location-specific reservoir species
(242). Numerous species causing cutaneous leishmaniasis have
been identified in multiple mammalian species. L. mexicana is
found from Central America to the Yucatan peninsula in Mex-
ico, and cases have been reported in Texas (250). In the Old
World, Leishmania major is a predominant cause of cutaneous
Leishmaniasis.
In Mexico, the first clinically documented records of cutaneous
leishmaniasis were from forested parts of the Yucatan Peninsula
(251, 252). Until 1989, only eight cases of visceral leishmania-
sis were reported; all of them were in the Balsas River basin,
which includes the States of Guerrero, Puebla, Morelos, and Oax-
aca (253). In Chiapas State, the first case was documented in
Tuxtla Gutiérrez in 1990. An increase in cases in several munici-
palities was observed in subsequent years. From 1990 to 2006, 89
cases of American visceral leishmaniasis were reported in Chiapas
State (254). In the US, human cases (n= 30) of non-travel-related
(or autochthonous) disease have been reported since 1903 in the
epidemic focus located in South-Central Texas. In 2008, nine
cases of non-travel-related cutaneous leishmaniasis in Northern
Texas, specifically in suburbs and smaller towns near the Dallas-
Ft. Worth metro area, were reported (255). Subsequently, four
cases of autochthonous cutaneous Leishmaniasis were described
in Northeastern Texas and Southeastern Oklahoma (256).
Several Leishmania species are transmitted zoonotically, and
in the case of L. infantum, dogs are the main reservoir. In many
settings, dogs may serve as a link between sylvatic and domestic
cycles of visceral leishmaniasis. Dogs can cross forest-edge bound-
aries, thereby potentially bringing parasites to or from sylvatic
systems and to and from other potential mammalian hosts (such
as foxes, rodents, and opossums) (242). In Yucatan, Mexico, the
prevalence of L. mexicana, L. infantum, and L. braziliensis in dog
sera (n= 218) was 30.2, 11.9, and 8.2%, respectively (257). Anti-
body based prevalence of 10.5% for L. mexicana and 11.57% for L.
braziliensis has also been reported in cats (258). Vertical transmis-
sion of leshmaniasis has been characterized for dogs and people,
causing an increased risk for infants born to parasitemic moth-
ers (259). There have also been a number of non-travel-associated
reports of cutaneous leishmaniasis in companion animals in Texas
(250). Many of these cases of zoonotic cutaneous leishmaniasis
were in cats, which may be associated with an outdoor life-style
(250). Until recently, visceral leishmaniasis was thought to be
primarily an imported disease in North America. Infected dogs
had usually been imported from regions in Southern Europe or
South America where L. infantum and L. chagasi were enzootic
(260, 261). Additional risk factors for humans are related to their
immunologic status and their ability to clear infection or maintain
an asymptomatic state. These factors include concurrent infection
with HIV, co-infections with helminthic parasites, drug abuse, and
other immunosuppressive conditions (262).
A serosurvey conducted in the US looked at over 12,000 fox-
hounds and other canids, as well as 185 people in 35 States, to
determine geographic extent, prevalence, host range, and modes
of transmission. This study showed that foxhounds infected with
Leishmania spp. were present in 18 States. However, no evidence
of infection was found in humans (263). While companion ani-
mal infection and transmission occur, the predominant sylvatic
reservoir in Texas is the Southern Plains woodrat, Neotoma micro-
pus (264). Given the presence of sand fly vectors throughout the
Southern US, it is possible that disease rates associated with L.
mexicana infection will increase in the US due to climate change
(14). South American species causing cutaneous leishmaniasis,
including L. amazonensis, L. braziliensis, L. guyanensis, and L. pana-
mensis, have sylvatic reservoirs (242). Thus, human risk factors for
zoonotic cutaneous leishmaniasis are dependent upon exposure
to vector species and the presence of reservoir species. Urban-
ization and wilderness encroachment have resulted in increased
interactions between humans, reservoir, and vector species and
the establishment of peri-urban domestic life cycles rather than
sylvatic ones (242).
In Mexico, Lutzomyia olmeca olmeca, Lu. cruciata, Lu. shan-
noni, Lu. panamensis, and Lu. ylephiletor have been incriminated
as vectors of Leishmania spp. (14, 265). In Northern Mexico and
US, sand fly species suspected of being involved in Leishmania
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transmission to humans are Lu. diabolica and Lu. anthophora (266,
267). Lu. diabiolica is suspected of being a vector of L. mexi-
cana and has been infected experimentally with L. infantum. In
addition, Lu. anthophora was able to transmit L. mexicana exper-
imentally to mice (268, 269). Lu. shannoni is a possible vector
of L. infantum, and is present in the Midwestern, Southern, and
Southeastern US (263). The sand fly vectors of L. infantum caus-
ing visceral leishmaniasis in Mexico include Lu. longipalpis and
Lu. evansi (270). Visceral leishmaniasis cases have been reported
in the States of Chiapas, Guerrero, Puebal, Oaxaca, morelos, and
Veracruz where dogs are considered to be disease reservoirs (270).
The pathogenic landscape for leishmaniasis in the transbound-
ary region remains to be fully understood (271). In Mexico and the
US, the risk for leishmaniasis has been associated with forest habi-
tat like pluvial rainforest and agricultural fields close to the forest
where reservoir mammals share habitat with humans. However,
the incidence of leishmaniasis is increasing in domestic habitats as
a direct consequence of the spreading of sand fly vectors to urban-
ized areas, especially the outskirts of cities (272). Moo-Llanes and
collaborators (271) studied the current and future niche of North
and Central American sand flies and concluded that continued
landscape modification and future climate change will provide
an increased opportunity for the geographic expansion of sand
flies and increased risk for human exposure to Leishmania infec-
tion. The One Health paradigm could also be applied to enhance
our ability to recognize Leishmania spp. in humans, domestic
and wildlife reservoirs, and sand fly vectors in the US-Mexico
transboundary region (273).
Chagas
Chagas is a zoonosis caused by Trypanosoma cruzi, a protozoan
parasite that is present in a variety of mammalian reservoirs. This
disease is one of the most prevalent parasitic diseases in the world
(274) and kills around 45,000 people annually (275). The para-
site is transmitted by species of insect vectors, commonly known
as kissing bugs, belonging to the sub-family Triatominae in the
family Reduviidae (276, 277). During the blood meal, the Tri-
atomine kissing bug defecates and sheds the parasite in the feces.
The parasite then enters its host through the bite wound or through
contact with mucous membranes. The parasite can also be trans-
mitted through blood transfusion, organ transplants, ingestion
of infected food, or congenital transfusion (277). However, 85–
96% of T. cruzi transmission to humans occurs via contact with
infected feces from Triatomine insects (278). The acute phase of
the disease is rarely recognized since cases are typically subclini-
cal and asymptomatic. Chagas disease can then enter the chronic
phase, in which 30% of cases will develop a fatal cardiomyopa-
thy around 10–30 years post-infection (274, 279). Anti-parasitic
treatment is mostly effective during the acute phase, and in infants
and individuals up to 15 years old, although the currently accepted
therapeutic options have limited efficacy and can have disabling
side effects. Current research includes efforts to develop a vaccine
for Chagas (11).
Chagas is endemic in the Southern US and Latin America,
where it affects more than 10 million people (280) and it is
spreading rapidly to non-endemic areas (276). It is considered
a NTD in Texas (11), and Chagas could have been present in
hunting-gatherer native Americans as far back as 1200 years ago,
as described in a case of megacolon found in a mummified
ancient resident of what is now known as Texas (281, 282). Studies
conducted in US blood donors have demonstrated that T. cruzi
seropositive donors have persistent infection with demonstrable
parasitemia long after acquisition of infection (283). In Texas, for
example, there are an estimated 267,000 people infected (284, 285).
This is only an estimate based on small sero-prevalence studies
and risk modeling. The exact risk for infection and the number of
Chagas cases in Texas is unknown (277). In January 2013, Chagas
became a reportable condition in Texas, which is a critical step
toward documenting cases and understanding the epidemiology
of this critical NTD.
There are several Chagas endemic areas in Mexico, including
the States of Yucatán, Chiapas, Guerrero, Oaxaca, Jalisco,Veracruz,
Puebla, Hidalgo, and Morelos where the disease occurs mainly
in rural areas (286). The highest prevalence was observed in the
Northeastern region of the country, which corresponds to the cen-
tral area of a tropical region comprising the States of Hidalgo,
San Luis Potosí, Veracruz, and the US neighbor State of Tamauli-
pas (287, 288). Recent cases of Chagas have been reported in
Coahuila (289, 290) where T. cruzi infection has been found also
in blood donors (290). There have been new records of T. ger-
staeckeri and T. rubida in Nuevo Leon and Coahuila (291). As in
the US, T. cruzi is increasingly transmitted through blood transfu-
sions partly due to migration from rural areas toward Mexico City
(292). More than 180 domestic, synanthropic, and wild species
of mammals, especially rodents and marsupials, are likely to be
infected with T. cruzi and to be involved in the disease trans-
mission cycle (293). In the Yucatan peninsula, the anti-T. cruzi
antibody prevalence in dogs and cats were determined to be 14.76
and 4.21%, respectively (258, 294). In addition, an active canine T.
cruzi transmission cycle with severe symptoms affecting a broad
range of dog breeds and age groups was observed in several coun-
ties in Texas (295). Further, in regions of Central Mexico, studies
have demonstrated that canine sero-prevalence is directly corre-
lated to human sero-prevalence, demonstrating the importance
of this host as a sentinel species (296). Serosurveillance in shelter
dogs was found useful as a public health tool to assess the risk for
T. cruzi infection (297).
Currently, 40 species of triatomine insects are known to be
naturally infected with T. cruzi in North America. Twenty-eight
species are found exclusively in Mexico, and eight are shared with
the US (298). Considering the vectorial transmission capacity
and widespread distribution in Mexico, important species include
Triatoma barberi, T. dimidiata, T. phyllosoma, T. longipennis, T.
mazzottii, T. pallidipennis, T. picturata, T. mexicana, and T. ger-
staeckeri (299, 300). T. gerstaeckeri and T. sanguisuga are the most
common triatomine species in the Southern US and might be
involved in T. cruzi transmission. Different reports have revealed
information about the major vectors in endemic areas of Mexico
(287). In the State of Veracruz, the main recognized vectors are T.
dimidiata and R. prolixus, and three vector species, P. rufotuber-
culatus, R prolixus, and T. dimidiata, have been identified in the
State of Chiapas. Two important vectors in the Southern region of
the State of Mexico are T. pallidipennis (97.4%) and T. dimidiata
(2.6%), and 28.0% of the triatomines in that region were infected
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with T. cruzi (299). Studies conducted in rural communities of
Yucatan, Mexico found that 21.9% of T. dimidiata (23.9% of adults
and 13% of nymphs) were infected with T. cruzi (301).
An accepted strategy to control and prevent Chagas disease
is through the management of triatomine insect infestations in
domestic areas based on government and population surveil-
lance programs (302). These programs have been successful in
South America, including Mexico. However, a surveillance pro-
gram aimed at controlling triatomine vectors and preventing
Chagas disease has not been attempted in the US, perhaps due
to the lack of data on human cases and vector-parasite distribu-
tion. Triatomine insects can be found in domestic and sylvatic
life cycles, which could make efforts to control insect infesta-
tions difficult in domestic habitats due to the continuity of insect
populations (303).
Recent models of risk assessment have identified Hidalgo and
Cameron counties as the areas of highest risk for human infec-
tion of Chagas disease in Texas (277). Hidalgo County has suitable
climatic conditions for the vector (304). This risk factor could be
compounded by a high poverty rate among the border popula-
tion and substandard housing. In Hidalgo County alone, almost
130,000 people live in unincorporated residential areas known as
colonias. Much of this population is characterized by low incomes
(<$10,000 per year) and poorly constructed residences with sub-
standard sanitation and drainage systems, which are landscape
characteristics that provide suitable habitat for Triatomine insects
(11, 277). Hidalgo and Cameron County form part of the Lower
Rio Grande Valley (LRGV), one of the main points of entry for
immigrants from Latin America, mainly Mexico. Since Chagas
disease is endemic to tropical areas, it is possible that migrants can
carry the disease into the US via the LRGV (11). Because Chagas
became a reportable disease in Texas in 2013, it can be argued that
sufficient epidemiologic data are lacking to implement a scientif-
ically sound disease control and prevention program yet. To be
effective, a management program to control and prevent Chagas
disease in south Texas will probably need to be combined with gov-
ernment and population-based surveillance of insect infestation.
Important challenges to overcome include a lack of knowledge
among the local population about Chagas disease and how to
identify insect vectors.
Climate change could drive enhanced transmission of T. cruzi
(12). A potential Northern shift from current range due to climate
change could occur with two of the most common triatomine T.
cruzi vectors in the Southern US (T. gerstaeckeri and T. sanguisuga).
Furthermore, an increase in temperature may have influenced
the behavior of triatomine species (305, 306). When tempera-
ture exceeds 30°C and humidity is low, the insects increase their
feeding rate to avoid dehydration. In addition, in domestic life
cycles, when indoor temperatures increase, the insects may develop
shorter life cycles and reach higher population densities (305).
High temperatures could also speed up the development of T.
cruzi in vectors (307).
Trypanosoma cruzi has three infective forms capable of infect-
ing its host and currently six DTUs (discrete typing units) are
recognized in the taxon. These DTUs correlate with mammalian
hosts specific interactions in distinct time-space scales. We know
relatively little about confirmed mammalian T. cruzi hosts in the
US. More studies are needed to produce a comprehensive list
of confirmed T. cruzi hosts as well as time-space scales for the
operative interactions of hosts, vectors, and parasites. To better
understand the epidemiology of Chagas disease in the Texas–
Mexico transboundary region, ongoing research could focus on
detecting T. cruzi infection status of vectors, potential role of the
different reservoirs and hosts in the parasite cycles, and DTUs
identification (12).
CONCLUDING REMARKS
The threat of zoonotic diseases to human and animal popula-
tions in the Mexico–US border along the Rio Grande is doc-
umented here. Attention is called to a gap in understanding
of the pathogenic landscape for zoonotic vector-borne diseases
in this transboundary region. Among other things, research on
ecosystem processes, land use, and human behaviors is required
because the region analyzed functions as a pathway for the move-
ment of humans and animal migrations, and thus links Central
America/Mexico with the US and Canada. The One Health
approach for international collaboration on veterinary and public
health research is proposed to generate the knowledge base that
can translate into strategies to mitigate the risk of zoonotic diseases
in the US–Mexico border.
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